🇨🇦 Amodiaquine Sulfadoxine-Pyrimethamin administration in Canada

Amodiaquine Sulfadoxine-Pyrimethamin administration (Amodiaquine Sulfadoxine-Pyrimethamin administration) regulatory status in Canada.

Marketing authorisation

Amodiaquine Sulfadoxine-Pyrimethamin administration in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Amodiaquine Sulfadoxine-Pyrimethamin administration approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Amodiaquine Sulfadoxine-Pyrimethamin administration in Canada?

Institut de Recherche en Sciences de la Sante, Burkina Faso is the originator. The local marketing authorisation holder may differ — check the official source linked above.